Evidence map›Paper›PMID 20498261›Full record

ArticleInfection and immunity2010

CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.

Elizabeth Charles, Sunil Joshi, John D Ash, Barbara A Fox, A Darise Farris, David J Bzik, Mark L Lang, Ira J Blader

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Interferons andFrontiers in immunology · 2025
    Article
  3. Review
  4. Role of the PD-1/PD-L1 Pathway in ExperimentalFrontiers in immunology · 2022
    Article
  5. Review
  6. Review
  7. Disease Tolerance inFrontiers in cellular and infection microbiology · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elizabeth CharlesDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Oklahoma City, OK 73104, USA.
Sunil Joshi
John D Ash
Barbara A Fox
A Darise Farris
David J Bzik
Mark L Lang
Ira J Blader
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

T GONDII--PYRIMIDINE SYNTHESIS AS A CHEMOTHERAPY TARGETR01AI041930 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 1997 to 2013
$4.2M
Cytokine Regulation of Photoreceptor Gene ExpressionR01EY016459 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ASH, JOHN D · 2006 to 2017
$4.0M
T cell to tolerance &autoimmunity to nuclear antigen LaR01AI048097 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI FARRIS, A DARISE · 2001 to 2012
$2.3M
Regulation of humoral immunity by NKT cellsR01AI078993 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LANG, MARK L · 2009 to 2013
$1.6M
Regulated virulence and cyst maturation in Toxoplasma gondiiR21AI075931 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2008 to 2009
$440k
Enhanced homologous recombination in Toxoplasma gondiiR21AI073142 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2007 to 2008
$435k
Genetic models for post-genome functional analysis of Toxoplasma gondiiR21AI084570 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2009 to 2010
$435k
Functional analysis of CD8 T cell immune control in Toxoplasma gondii infectionR21AI091461 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2010 to 2011
$432k
Regulation of humoral immunity by NKT cellsR56AI078993 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LANG, MARK L · 2014 to 2014
$404k
NEI NIH HHS EY016459NEI NIH HHS R01 EY016459NIAID NIH HHS AI048097NIAID NIH HHS AI078993NIAID NIH HHS AI41930NIAID NIH HHS R01 AI041930NIAID NIH HHS R01 AI048097NIAID NIH HHS R01 AI078993NIAID NIH HHS R21 AI073142NIAID NIH HHS R21 AI075931NIAID NIH HHS R21 AI084570NIAID NIH HHS R21 AI091461NIAID NIH HHS R56 AI078993PHS HHS A069986
6 · The paper itself

Abstract

In the inflamed retina, CD4(+) T cells can cause retinal damage when they are not properly regulated. Since tissue expression of major histocompatibility complex (MHC) class II and costimulatory molecules is a key mechanism for regulating effector T cells, we tested the hypothesis that upregulation of these proteins in the retina contributes to the regulation of CD4 T cells. Here we report that in retinas infected with the protozoan parasite Toxoplasma gondii, MHC class II is upregulated on infiltrating leukocytes as well as on resident retinal cells, including photoreceptors. Flow cytometric analysis indicated that B7 costimulatory family members (CD80, CD86, ICOS-L, and programmed death ligand 2 [PD-L2]) were not expressed on class II(+) cells. In contrast, PD-L1 (also named B7-H1 or CD274) was expressed on the majority of both hematopoietic and resident retinal MHC class II-expressing cells. Retinal cells from Toxoplasma-infected animals were able to suppress T-cell activation in a PD-L1-dependent manner. Finally, we demonstrate that the expression of MHC class II and PD-L1 was critically dependent on gamma interferon (IFN-gamma) expression. These data suggest that retinal MHC class II and PD-L1 expression is a novel mechanism by which the retina protects itself from CD4 T-cell-mediated immune damage in ocular toxoplasmosis and other types of retinal immune responses.

Indexed as

AnimalsB7-1 AntigenB7-H1 AntigenCD4-Positive T-LymphocytesHistocompatibility Antigens Class IIImmune ToleranceLeukocytesMembrane GlycoproteinsMiceMice, Inbred C57BLPeptidesPhotoreceptor Cells, VertebrateRetinaToxoplasmaB7-1 AntigenB7-H1 AntigenCd274 protein, mouseHistocompatibility Antigens Class IIMembrane GlycoproteinsPeptides

Identifiers

PMID20498261
PMCPMC2916285
OpenAlexW2138022845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.